Update (June 22, 2012)

Jane started Cycle 12 today with the normal dose of the experimental drug ABT 348 and the more traditional chemotherapy drug, docetaxel.  The most difficult side effect thus far to manage has been a case of lymphedema in Jane's legs and lower extremities that causes Jane's legs to retain water and swell up. It is not only pretty painful but adversely effects her mobility. She maintains a positive outlook and is going to rehab and occupational therapy regularly to help in this area.

At the end of Cycle 12, about July 12th, the doctors will perform another series of diagnostic tests to measure the results of the drug's effectiveness.  After reviewing the results, the doctors will recommend a path forward. 

We continue to be grateful to everyone for their kind thoughts and prayers.  Our family and friends from all over manage to say and do the right things to help us along the way.  Hope everyone is having a terrific summer.  God bless.

No comments:

Post a Comment